Headache
Trigeminal Autonomic Cephalalgias
Migraine Headaches
Diagnosis
Classification
Clinical Management of Headaches
Patients with migraine report superior outcomes with ubrogepant compared to triptans
SAN DIEGO — Those with migraine who switched from an oral triptan to ubrogepant reported superior outcomes compared with patients who chose another triptan,, according to data presented at the American Headache Society Annual Scientific Meeting.
Serum vitamin levels key to proper assessment, management of pediatric chronic migraine
SAN DIEGO — Obtaining serum vitamin levels in children with migraine should be part of symptom management, particularly for older adolescents, according to a speaker at the American Headache Society Annual Scientific Meeting.
Nutrient intake lower on days with nausea or vomiting in episodic migraine
SAN DIEGO —Individuals with episodic migraine had lower nutrient intake on days with nausea or vomiting compared with days without nausea, according to a poster from the American Headache Society Annual Scientific Meeting.
AI-based models accurately predict, show promise for expansion in headache
SAN DIEGO — AI-based models are currently best utilized as a predictor of headache, but show promise for expansion into the health care continuum, according to a speaker at the American Headache Society Annual Scientific Meeting.
Concurrent atogepant, ubrogepant safe, well-tolerated for migraine at 12 weeks
SAN DIEGO — Concurrent use of atogepant for preventive treatment of episodic migraine and ubrogepant for acute migraine treatment was safe and well-tolerated at 12 weeks, according to a study.